GlassScriptPhysician profile
Jasgurpreet Singh
NPI 1619587169
$3,608.13
in general payments reported to CMS, 2019-2025
19 companies · $1,889 in 2025
The $1,889 reported for 2025 was more than what 79% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $40.86 · 2021: $963 · 2022: $495 · 2024: $220 · 2025: $1,889.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,141 · Travel and Lodging: $968.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,141.30 |
| Travel and Lodging | $968.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,749.01 | 2021-2025 | Solyx Sis System, General - Female Sui, Ams 800 Artificial Urinary Sphincter |
| Urogen Pharma, INC. | $198.02 | 2024-2025 | |
| Janssen Biotech, INC. | $149.64 | 2025 | Tremfya |
| Endo USA, INC. | $71.99 | 2024-2025 | Xiaflex |
| Convatec INC. | $71.13 | 2020-2021 | |
| Procept Biorobotics Corporation | $53.68 | 2024-2025 | Aquabeam System |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $46.50 | 2025 | Xifaxan |
| Valencia Technologies Corporation | $33.63 | 2025 | Ecoin Device Kit |
| Organogenesis INC. | $30.25 | 2025 | Puraply Wound Matrix |
| Leica Microsystems INC. | $27.02 | 2025 | Neoprobe |
| Axonics, INC. | $26.06 | 2024 | Axonics |
| Teleflex LLC | $23.33 | 2025 | Urolift |
| Ardelyx, INC. | $21.84 | 2025 | Ibsrela |
| Takeda Pharmaceuticals U.S.A., INC. | $20.00 | 2025 | Eohilia |
| Karl Storz Endoscopy-America | $19.86 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $19.11 | 2025 | |
| Madrigal Pharmaceuticals | $16.54 | 2025 | Rezdiffra |
| Vertex Pharmaceuticals Incorporated | $15.54 | 2024 | |
| Intercept Pharmaceuticals, INC. | $14.98 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jasgurpreet Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.